featured
ATX-101 for Submental Fat Reduction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Dermatologic Surgery
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Dermatol Surg 2016 Jan 01;42(1)38-49, DH Jones, J Carruthers, JH Joseph, VD Callender, P Walker, DR Lee, M Subramanian, PF Lizzul, TM Gross, FC BeddingfieldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.